The Mycobacterium avium ssp. paratuberculosis specific mptD gene is required for maintenance of the metabolic homeostasis necessary for full virulence in mouse infections by Thorsten MeiÃŸ et al.
ORIGINAL RESEARCH ARTICLE
published: 14 August 2014
doi: 10.3389/fcimb.2014.00110
The Mycobacterium avium ssp. paratuberculosis specific
mptD gene is required for maintenance of the metabolic
homeostasis necessary for full virulence in mouse
infections
Thorsten Meißner1, Elke Eckelt1, Tina Basler1, Jochen Meens1, Julia Heinzmann1†,
Abdulhadi Suwandi2, Walter M. R. Oelemann3,4, Sandra Trenkamp5, Otto Holst4, Siegfried Weiss2,
Boyke Bunk6,7, Cathrin Spröer6,7, Gerald-F. Gerlach1† and Ralph Goethe1*
1 Department of Infectious Diseases, Institute for Microbiology, University of Veterinary Medicine Hannover, Hannover, Germany
2 Helmholtz Centre for Infection Research, Molecular Immunology, Braunschweig, Germany
3 Departamento de Imunologia, Instituto de Microbiologia Paulo Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
4 Division of Structural Biochemistry, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel, Germany
5 Metabolomic Discoveries GmbH, Potsdam-Golm, Germany
6 Bioinformatics, Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
7 German Centre of Infection Research, Partner Site Hannover-Braunschweig, Braunschweig, Germany
Edited by:
Wolfgang Eisenreich, Technische
Universität München, Germany
Reviewed by:
Maria Júlia Manso Alves, University
of São Paulo, Brazil
Adel M. Talaat, University of
Wisconsin Madison, USA
*Correspondence:
Ralph Goethe, Zentrum für
Infektionsmedizin, Institut für
Mikrobiologie, Stiftung Tierärztliche
Hochschule Hannover, Bischofsholer
Damm 15, 30173 Hannover,
Germany
e-mail: ralph.goethe@
tiho-hannover.de
†Present address:
Julia Heinzmann, Institute of Farm
Animal Genetics, Federal Research
Institute of Animal Health,
Friedrich-Loeffler-Institut, Neustadt,
Germany;
Gerald-F. Gerlach, Innovative
Veterinary Diagnostics Laboratory
GmbH, Hannover, Germany
Mycobacterium avium subspecies paratuberculosis (MAP) causes Johne’s disease, a
chronic granulomatous enteritis in ruminants. Furthermore, infections of humans with
MAP have been reported and a possible association with Crohn’s disease and diabetes
type I is currently discussed. MAP owns large sequence polymorphisms (LSPs) that
were exclusively found in this mycobacteria species. The relevance of these LSPs in the
pathobiology of MAP is still unclear. The mptD gene (MAP3733c) of MAP belongs to
a small group of functionally uncharacterized genes, which are not present in any other
sequenced mycobacteria species. mptD is part of a predicted operon (mptABCDEF),
encoding a putative ATP binding cassette-transporter, located on the MAP-specific LSP14.
In the present study, we generated an mptD knockout strain (MAPmptD) by specialized
transduction. In order to investigate the potential role of mptD in the host, we performed
infection experiments with macrophages. By this, we observed a significantly reduced cell
number of MAPmptD early after infection, indicating that the mutant was hampered with
respect to adaptation to the early macrophage environment. This important role of mptD
was supported in mouse infection experiments where MAPmptD was significantly
attenuated after peritoneal challenge. Metabolic profiling was performed to determine the
cause for the reduced virulence and identified profound metabolic disorders especially in
the lipid metabolism of MAPmptD. Overall our data revealed the mptD gene to be an
important factor for the metabolic adaptation of MAP required for persistence in the host.
Keywords: Mycobacterium infections, metabolism, lipids, macrophages, survival
INTRODUCTION
Mycobacterium avium subspecies paratuberculosis (MAP) belongs
to the M. avium complex (MAC), which comprises subspecies of
M. avium with different extents of host adaptation and virulence.
For instanceM. avium subsp. hominissuis is found ubiquitously in
the environment and causes opportunistic infections in humans,
pigs and ruminants, whereas M. avium subsp. avium is the
causative agent of tuberculosis in birds (Thorel et al., 1990; Mijs
et al., 2002; Dvorska et al., 2003; Dhama et al., 2011; Ignatov et al.,
2012). In contrast, MAP is an obligate pathogen for ruminants
causing Johne’s disease (JD, paratuberculosis) - a chronic gran-
ulomatous enteritis (Kreeger, 1991; Harris and Barletta, 2001).
Moreover, infections of humans with MAP have been reported
and a possible association with Crohn’s disease and more recently
with diabetes type I has been discussed (Greenstein, 2003; Feller
et al., 2007; Mendoza et al., 2009; Rani et al., 2010; Rosenfeld and
Bressler, 2010; Cossu et al., 2011; Chiodini et al., 2012; Naser et al.,
2014).
JD is characterized by an extending transmural inflamma-
tion of the intestine without caesification of the granulomas.
Noteworthy, lesions in other areas are less common, indicating
a specific tropism of MAP for the intestine which is not seen in
other mycobacteria (Buergelt et al., 1978; Clarke, 1997; Burrells
et al., 1998). The intestinal tropism of MAP is particularly evident
in ruminants, but it has become apparent that the organism has
a much broader host range including monogastric species such
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as carnivore (fox, stoats), aves (crow and jackdaw), lagomorpha
(rabbits) and recentlyminiature donkeys (Greig et al., 1999; Beard
et al., 2001; Glanemann et al., 2008; Stief et al., 2012; Carta et al.,
2013).
The pathobiology of MAP infection including its tropism to
the gut is still unresolved. After crossing the intestinal barrier,
MAP is taken up by intestinal macrophages and there is com-
mon consensus that the persistence in these macrophages is the
key step in MAP infection (Ryan et al., 2014). Nevertheless, the
persistence in macrophages, characterized by inhibition of the
phagosomal maturation process, altered antigen processing and
presentation is a common feature of any pathogenic mycobacte-
rial species and might not explain the characteristics of intestinal
MAP infection (Kuehnel et al., 2001; Hostetter et al., 2002;
Vergne et al., 2004). However, MAP additionally inhibits T cell
and Dendritic cell (DC) activation and restricts the macrophage
inflammatory cytokine response in cell culture systems (zur Lage
et al., 2003; Basler et al., 2010, 2013). Thus, it seems that MAP
persists and survives in its intestinal niche by subverting the
immune defense mechanisms of the host and therefore might
remain locally restricted to the intestine for long time (Atreya
et al., 2014). In addition, on the bacterial side consequences of
infection are characterized by a strong metabolic adaptation to
the intestinal environment of the host (Weigoldt et al., 2011,
2013), which suggest that this capacity considerably adds to MAP
pathobiology.
Within the MAC, MAP exhibits particular phenotypic fea-
tures in culture. Thus, MAP growth in culture is dependent
on mycobactin supplementation, extremely slow with the aver-
age doubling time of 22–26 h (other MAC ssp. 10–12 h), and
shows a strong tendency to clump formation (Merkal and Curran,
1974). Differences in the phenotype and virulence of MAP might
be linked to MAP specific genes (Li et al., 2005) and/or the
acquisition, loss and rearrangement of specific genetic elements
(Alexander et al., 2009). Sixteen large sequence polymorphisms
(LSPs) were exclusively found in MAP. Six out of these 16 LSPs
are common in all MAP strains and considered to be genomic
insertions. These insertions comprise ∼125 kb of DNA with 82
open reading frames (ORFs), with most of them being not of
mycobacterial origin but exhibiting similarities to genes from
environmental actinomycetes (Marri et al., 2006). Yet it is not
clear whether the genes encoded onMAP-specific LSPs contribute
to the phenotype and pathogenicity of MAP.
Previously, we had identified a MAP-specific putative 38 kb
pathogenicity island which is located on LSP14, the largest LSP
found inMAP. LSP14 harborsmostly genes which encode for pro-
teins with predicted functions in metal metabolism (Stratmann
et al., 2004). Within the 38 kb DNA region, a predicted operon
mptABCDEF encodes for two putative ATP binding cassette
transporters. ThemptABCDEF operon (MAP3736c-31c) exhibits
the highest similarity to other genera of the order Actinomycetales
such as Salinispora or Bifidobacter and to a lesser extent to other
mycobacteria. In addition, these genes have no other orthologs in
MAP (data not shown). Among the operon genes,mptD is unique
inMAPwithin the genus ofMycobacterium since it is present in all
sequenced cattle- and sheep-type MAP strains, but it is not found
in any other so far sequenced mycobacterial species, even not in
other subspecies of the MAC. Interestingly, mptD was found to
be surface-exposed and expressed during infection (Stratmann
et al., 2004; Shin et al., 2006). In addition, Cossu and colleagues
found antibodies against mptD in sera of type I diabetes mellitus
patients (Cossu et al., 2011), suggesting a possible role ofmptD in
MAP pathogenicity in humans.
In the present study, we used specialized transduction to gen-
erate a mptD knockout strain. By different comparative analyses
we found that the gene is important for the metabolic home-
ostasis of MAP, which appears to be necessary for adaptation to
the macrophage environment and survival in a mouse infection
model.
MATERIALS AND METHODS
BACTERIAL STRAINS, CHEMICALS, AND GROWTH CONDITIONS
All chemicals were purchased from Sigma-Aldrich (Munich,
Germany) if not stated otherwise. All bacterial strains, phages,
and plasmids are listed in Table S1. The Escherichia coli strains
DH5α and HB101 and theM. smegmatismc2 155 strain were cul-
tured in Luria-Bertani (LB) broth or on LB agar plates (Roth,
Karlsruhe, Germany) containing appropriate antibiotics with a
concentration of 100μg/ml. The E. coli strains DH5α and HB101
were used for cloning of homologous regions and for con-
struction of the allelic exchange substrate (AES) in pYUB854.
Additionally, E. coli HB101 was used for the in vitro λ-packaging
reaction (GIGApack® II plus kit, Stratagene, La Jolla, CA, USA).
For transformation experiments, competent E. coli HB101 were
prepared following standard procedures (Sambrook and Russell,
2001). Liquid cultures of E. coli and M. smegmatis were grown at
37◦C in a shaking incubator. M. smegmatis mc2 155 was used for
the generation of high titer phage lysates and phage construction
as described (Carriere et al., 1997). M. avium subsp. paratuber-
culosis strain DSM 44135 (MAPwt) (Stratmann et al., 2004) was
grown in Middlebrook 7H9 broth (MB7H9) or on Middlebrook
7H10 agar supplemented with 10% OADC and mycobactin J
(2mg/l; Allied Monitor, Fayette, USA). MB7H9 medium was
further supplemented with Tween® 80 (0.05% final concentra-
tion) unless stated otherwise. For growth experiments, MAPwt
and the mutant strain MAPmptD were cultured in supple-
mented MB7H9 medium until an OD600 of 3.0 was reached. The
bacteria were then harvested, washed two times with phosphate-
buffered saline (PBS) and diluted in supplemented MB7H9 with-
out Tween® 80 to an OD600 of 0.2. Bacteria were cultivated with
stirring at 120 rpm at 37◦C and OD600 was measured every 2–3
days until entry of stationary phase.
DNA TECHNIQUES
Chromosomal mycobacterial DNA was prepared according to
standard procedures (Belisle and Sonnenberg, 1998). Plasmids of
E. coli were isolated using the NucleoSpin Plasmid kit (Macherey-
Nagel, Düren, Germany) according to themanufacture’s protocol.
Southern blot analyses were performed with EcoRV-restricted
chromosomal DNA according to standard protocols (Sambrook
and Russell, 2001), using a α32-P-dCTP labeled PCR fragment
obtained with primers omptD3a and omptD4a as a DNA probe.
After hybridization, membranes were exposed to X-ray film
(Kodak X-OMAT® Biomax, Sigma Aldrich GmbH, Deisenhofen,
Frontiers in Cellular and Infection Microbiology www.frontiersin.org August 2014 | Volume 4 | Article 110 | 2
Meißner et al. Role of mptD for MAP pathogenicity
Germany). Polymerase-chain-reactions (PCR) were run on a
Mastercycler system (Eppendorf, Hamburg, Germany), using
HotStart HiFidelity Polymerase (Qiagen, Hilden, Germany) and
the following conditions: 95◦C for 10min, 95◦C for 45 s, 58◦C
for 60 s, and 72◦C for 60 s. The oligonucleotides are listed in
Table S1.
CONSTRUCTION OF MAPmptD
The construction of the specialized transducing mycobacterio-
phage containing the AES was performed according to Park and
colleagues (Park et al., 2008) with slight modifications. A detailed
protocol is given in the supplementary methods file. Briefly, in
order to generate an mptD (MAP3733c) deletion in MAP, two
oligonucleotide primer pairs (Table S1) were generated to amplify
the up- and downstream flanking regions of the mptD gene
resulting in an deletion of 518 bps of themptDORF upon restric-
tion digest and ligation of the amplified products into the cosmid
vector pYUB854 (Bardarov et al., 2002). The resulting construct
pMP1310 was introduced into the mycobacterial phage vector
phAE87 (Bardarov et al., 1997), resulting in phage phAE111. To
construct a MAPmptD mutant, MAP was cultured in MB7H9
medium to OD600 of 1.0. Bacterial suspensions of MAP, free
of clumps, were transduced and plated on MB7H10 agar plates
containing 50μg/ml hygromycin B and incubated at 37◦C for
up to 12 weeks. Successful recombination was confirmed by
PCR, Southern blot and quantitative real-time PCR (qRT-PCR)
analyses (Figures 1A–C).
PacBio RSII RESEQUENCING STUDY
SMRTbell™ template library was prepared according to the
instructions from PacificBiosciences, Menlo Park, CA, USA, fol-
lowing the Procedure and Checklist Greater than 10 kb Template
Preparation and Sequencing. Briefly, for preparation of 10 kb
libraries, ∼10μg genomic DNA were end-repaired and ligated
overnight to hairpin adapters applying components from the
DNA/Polymerase Binding Kit P4 from Pacific Biosciences, Menlo
Park, CA, USA. Reactions were carried out according to the man-
ufacturer’s instructions. SMRTbell™ template was Exonuclease
treated for removal of incompletely formed reaction products.
Conditions for annealing of sequencing primers and binding of
polymerase to purified SMRTbell™ template were assessed with
the Calculator in RS Remote, PacificBiosciences, Menlo Park,
CA, USA. SMRT sequencing was carried out on the PacBio RSII
(PacificBiosciences, Menlo Park, CA, USA) taking one 180-min
movie for each SMRT cell. In total 1 SMRT cell was run.
RNA EXTRACTION AND QUANTITATIVE REAL-TIME PCR
Total RNA was extracted from MAPwt and MAPmptD grown
to mid log phase (OD600 of 1.0) using a TRIzol®protocol accord-
ing to Rustad et al. (2009). RNA was additionally purified using
FIGURE 1 | Confirmation and characterization of MAPmptD mutant by
Southern blot analysis (A,B), qRT-PCR (C,D) and growth experiments (E).
(A) EcoRV restricted genomic DNA of MAPwt (lane 2) and MAPmptD
mutant strain (lane 3), Southern blotted and hybridized with a probe against
mptE (MAP3732c). In the wild type a 4.9 kbp fragment is labeled, the mutant
strain shows a 1.8 kbp fragment. Lane 1 DNA marker. (B) Genomic sketch of
the mpt region spanning genes mptF (MAP3731c) to mptA (MAP3736c) in
MAPwt (top) and mptD mutant strains (bottom). Position of EcoRV
restriction sites are indicated, the α32-P-dCTP labeled probe fragment is boxed.
(C) Transcription of mptD (black bars) and hygromycin (hyg) (white bars) in
MAP wild type (wt) and MAPmptD were analyzed by qRT-PCR. As a control,
cDNA samples were tested for the housekeeping gene gap (gray bars). (D)
Analysis of mptE (MAP3732c) transcription in MAPwt and MAPmptD by
qRT-PCR (n.s., no significant difference). (E) Growth of MAPwt and
MAPmptD in Middlebrook 7H9 medium. Cultures were inoculated with an
initial OD600 of 0.2 and growth was monitored at OD600 (ordinates) at different
time points (abscissa) until stationary phase. The results of (C,D) represent
the mean ± standard error (s.e.m.) of three replicates.
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an RNeasyMini kit (Qiagen, Düsseldorf, Germany) with DNase I
(50U) in tube treatment according to the manufacturer’s man-
ual. DNAse digested RNA was used for double strand cDNA-
synthesis. Briefly, in a total volume of 20μl, 4μg of RNA were
mixed with 0.4μg random primers (Promega, Madison, WI,
USA), incubated for 10min at 70◦C in a thermal cycler and subse-
quently cooled on ice for 5min. Aliquots (10μl) were mixed with
5μl 5× reaction buffer and 2μl 10mM dNTP’s in a total volume
of 25μl. Reverse transcription was performed by adding either
200U MMLV-superscript transcriptase (Promega, Madison, WI,
USA) or RNase free water as a negative control. Reactions were
incubated for 1 h at 42◦C, followed by an incubation for 5min
at 85◦C. Samples were diluted with 90μl ddH2O and stored at
−20◦C until further analysis.
For real-time PCR experiments, 2.5μl of cDNA were mixed
with 0.4μM primer each and 10μl SYBR-Green Mix (Qiagen,
Hilden, Germany) in a total volume of 20μl and subsequently
analyzed using a Mx3005P qPCR system (Stratagene, Agilent
Technologies, La Jolla, CA, USA) with a thermal cycling profile
as follows: segment 1, 20min at 95◦C, 1 cycle; segment 2, 45 s at
95◦C, 1min at 58◦C, 1min at 72◦C, 45 cycles; segment 3, 1min
at 95◦C, 30 s at 55◦C, 30 s at 95◦C, 1 cycle. Results were normal-
ized to the housekeeping gene gap (MAP1164) and expressed as
fold-change to the untreated control.
METABOLOMIC SCREEN
For metabolomic screening, three independent biological repli-
cates of MAPwt and MAPmptD were grown to mid log
phase (OD600 of 1.0) in supplemented MB7H9 medium. To
stop metabolic activity, 15ml of each culture were transferred
to a quenching solution (60% methanol kept at −20◦C) in a
dilution of 1:3 (vol/vol). Bacteria were harvested by centrifu-
gation at 4◦C at 8000 × g for 3min, pellets were washed
with 1ml quenching solution and bacteria were pelleted again.
Supernatants were removed and pellets were resuspended in
1ml 80% methanol (−20◦C) for metabolite extraction. Ten
microliter of an internal standard (0.2mg of 13C6 labeled sor-
bitol in 1ml methanol) were added to the samples. Samples
were transferred to a Fastprep tube and disrupted in a bead
beater using four cycles at intensity setting 6.5 for 40 s with
intermediate cooling on ice. Samples were incubated at 70◦C
for 15min, centrifuged at 4◦C at 4000 × g for 15min, and
10μl were transferred to an appropriate glass tube for freeze-
drying overnight. Dried samples and 300μl of undried sam-
ples were used for gas and liquid chromatography (GC/LC)
analyses, respectively. All subsequent steps were carried out
at Metabolomic Discoveries GmbH (Potsdam, Germany; www.
metabolomicdiscoveries.com). Derivatization and analysis of
metabolites in a GC-MS 7890A mass spectrometer (Agilent,
Santa Clara, USA) were carried out as described (Lisec et al.,
2006). Metabolites were identified in comparison toMetabolomic
Discoveries’ database entries of authentic standards. The LC
separation was performed using hydrophilic interaction chro-
matography with a ZIC-HILIC 3.5μm, 200 A column (Merck
Sequant, Umeå, Sweden), operated by an Agilent 1290 UPLC
system (Agilent, Santa Clara, CA, USA). The LC mobile phase
was a linear gradient from 90 to 70% acetonitrile over 15min,
followed by a linear gradient from 70 to 10% acetonitrile over
1min, 3min wash with 10% and 3min reequilibration with
90% acetonitrile. The flow rate was 400μl/min, the injection
volume was 1μl. The mass spectrometry was performed using
a 6540 QTOF/MS Detector (Agilent, Santa Clara, CA, USA).
The measured metabolite concentration was normalized to the
internal standard. Significant concentration changes of metabo-
lites in different samples were analyzed by normal distribution
(Shapiro–Wilk-Test) and variance homogeneity testing (F-Test)
using appropriate statistical test procedures (Students test, Welch
test, Mann–Whitney test) (see Tables S2A,B). A p-value of p <
0.05 was considered as significant.
LIPID PROFILING
MAPwt and MAPmptD (400 and 600mg lyophilized cells,
respectively) were suspended in 20ml of a mixture of chloro-
form/methanol (2:1, v/v) and extracted by sonication on ice
(Branson sonifier, output 4, duty cycle 40, 2 × 15min, pulsed).
After centrifugation at 3000 × g for 30min at 4◦C, the super-
natant was transferred and dried using a rotary evaporator yield-
ing 100 and 170mg of crude lipids, respectively. The crude lipids
were fractionated according to their polarity on 10 × 1.5 cm
columns filled with Silica gel K60 (0.04–0.063mm mesh size,
Merck, Darmstadt, Germany) sequentially using chloroform, ace-
tone and methanol (100ml each), followed by a final wash with
10ml of a mix containing equal volumes of chloroform and
methanol.
All fractions were evaporated and dry masses determined.
The lipid fractions were analyzed on high-performance thin-
layer chromatography (HPTLC) plates (Merck, Darmstadt,
Germany). Briefly, 10μg of each lipid fraction were applied
and resolved either in chloroform/methanol (9:1) or chloro-
form/methanol/water (65:25:4). Commercial trehalose dimyco-
late (TDM; Bioclot GmbH, Aidenbach, Germany), and a mixture
of phosphoinositol mannosides (PIMs) extracted from M. tuber-
culosis were included as marker. After evaporation of the solvent,
lipid bands were visualized by dipping the plates in a solution
of Hanessian’s stain [2.5mM cerium (IV) sulfate, 40mM ammo-
nium hepta-molybdate in 5.8% H2SO4] followed by heating to
150◦C for 5min.
MACROPHAGE CELL CULTURE AND VIABILITY ASSESSMENT OF
INTRACELLULAR MYCOBACTERIA
The mouse macrophage cell lines J774A.1 (Ralph et al., 1975) and
RAW264.7 (Raschke et al., 1978) were maintained in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10% FCS,
1% glutamine, 100 units/ml penicillin, 100μg/ml streptomycin at
37◦C and 8% CO2. For infection experiments, cells were main-
tained in antibiotic-free DMEM for 48 h. To determine mycobac-
terial viability during infections, macrophages were infected as
described (Kuehnel et al., 2001) with MAPwt and MAPmptD
in a multiplicity of infection (MOI) of 10:1. After infection at
the indicated time points, monolayers were washed twice with
PBS and scraped off the plates in 1ml of 1% Nonidet P40 in
PBS. Cells were disrupted by 10 passages through a 24-gauge
needle. A 10-fold serial dilution of the homogenates was pre-
pared in PBS and 100μl of each dilution level were plated on
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supplemented Middlebrook 7H10 agar plates. After incubation
for up to 12 weeks at 37◦C, the colony-forming units (cfu) were
counted.
BACTERIAL ADHESION ASSAY AND FLOW CYTOMETRY
Adhesion of mycobacteria was assayed by flow cytometry as
described previously (Pott et al., 2009; Basler et al., 2010).
Briefly, mycobacteria grown to an OD600 of 1.0 were fluores-
cently labeled using carboxyfluorescein succinimidyl ester (CFSE,
Life Technologies GmbH, Darmstadt, Germany) at 10μM final
concentration in PBS for 20min at 37◦C. After two washes in
PBS, labeled bacteria were resuspended in DMEM and used for
infection of macrophages. To quantify mycobacterial adhesion to
J774.A1 macrophages, confluent grown cells were pretreated with
latrunculin (1μg/ml) for 30min to inhibit phagocytosis and sub-
sequently incubated for 1 h with CFSE labeled MAPwt and MAP
mptD in a MOI of 10:1. Then, bacteria-containing medium was
removed, and cells were scraped off in PBS, washed for 5min with
PBS by overhead shaking at 4◦C, and pelleted by centrifugation at
250 × g for 5min. Washing was repeated twice. Cells were ana-
lyzed with a FACSCalibur (BD biosciences, San Jose, CA, USA).
Results were expressed as means ± standard error of the mean
(SEM) fluorescence intensities.
ANIMAL EXPERIMENT
The mouse infection experiments were approved by the Lower
Saxony Federal State Office for Consumer Protection and Food
Safety, Germany (reference number 08/1504). Female C57BL/6
mice aged 8 weeks (Charles River, Erkrath, Germany) were
used. Mice were infected intraperitonially (i.p.) with an infection
dose of 1 × 108 or 2 × 108 pathogens of each strain in 200μl
Dulbecco’s Phosphate-Buffered Saline (DPBS, Life Technologies
GmbH, Darmstadt, Germany; 10 mice per group). Application
of PBS was used as negative control. Two days postinfection the
body mass monitoring started and was repeated three times per
week. After 4 weeks mice were sacrificed, liver, spleen and mesen-
tery tissue were weighted, and MAP (MAPwt and MAPmptD)
were quantified by plating of the homogenized tissue onMB7H10
agar plates supplemented with 10% OADC and mycobactin.
Histology was performed in the Mouse Pathology platform at
HZI Braunschweig. Briefly, organs were fixed in 10% formalde-
hyde (v/v), dehydrated with ethanol, and embedded in paraffin.
Paraffin sections (0.5μm) were stained with hematoxylin-eosin
(HE) according to standard laboratory procedures. HE stained
slices of liver were investigated at 400×magnification and granu-
loma counts per area were determinedmanually using AxioVision
Le software (Carl Zeiss AG, Jena, Germany) based on the contrast
between granulomas (blue) and other cells of the liver (pink).
To minimize false positive results, only granuloma with a size
of >2000μm2 were counted and compared to the liver slices of
uninfected mice, where no granuloma have been detected.
STATISTICS
Data are expressed as mean ± s.e.m. By using GraphPad Prism
4.0 (GraphPad, San Diego, CA, USA) a parametric t-test or One-
Way ANOVA tests were used for statistical analyses of macrophage
and the animal experiment. Differences between treated samples
and controls were considered statistically significant at a level of
p < 0.05.
RESULTS
CONSTRUCTION OF MAPmptD
In order to gain insight into the role of mptD in MAP
pathogenicity we generated a mptD mutant strain by special-
ized transduction (Braunstein et al., 2002; Park et al., 2008). For
this, the mptD gene (MAP3733c) in MAP strain DSM44135 was
replaced by a hygromycin cassette. Hyg-resistant colonies were
picked and deletion of mptD was confirmed by Southern blot
hybridization and qRT-PCR analyses (Figures 1A–C). A posi-
tive clone designated MAPmptD was further propagated. To
exclude polar effects by the mutation on downstream genes, RNA
extracted fromOD600 of 1.0 cultures of MAPmptD andMAPwt
was analyzed by qRT-PCR. As shown in Figure 1D, the mRNA
expression level of the downstream gene mptE (MAP3732c) was
not affected in MAPmptD, excluding polar effects. On the other
hand, this implied that the following genes mptE and mptF were
not part of the predictedmptABCDEF.
Any illegitimate recombination in MAPmptD could be
excluded by PacBio resequencing study applying the RefSeq
genome of strain MAP-K10 (NC_002944.1, Li et al., 2005) in
the RS_Resequencing.1 protocol of SMRTPortal 2.1.1. Hereby,
coverage analysis using samtools mpileup (PMID 19505943) on
the resulting BAM-file confirmed no further large-scale dele-
tions in MAPmptD. Alignment analyses of PacBio long reads
by BLAST confirmed that the hygromycin cassette was inserted
nonrecurring and at exactly that position as expected.
Following, we analyzed growth of MAPmptD and MAPwt
in supplemented MB7H9 broth (Figure 1E). Both wild type and
mutant strains grew with similar kinetics and entered stationary
phase after 34 days. This indicated that mptD is not necessary for
growth of MAP in MB7H9.
REDUCED INTRACELLULAR SURVIVAL OF MAPmptD IN
MACROPHAGES
To investigate the potential role ofmptD in pathogenicity, we per-
formed survival experiments in murine RAW264.7 macrophages
and also included J774A.1 macrophages of which we had detailed
information of the phagosomal acidification process (Kuehnel
et al., 2001). Exponentially grown bacteria of MAPmptD
and MAPwt were harvested at an OD600 of 1.0, and single
cell suspensions of an OD600 of 0.1 in DMEM were used to
infect macrophages as described in Materials and Methods. CFU
were counted at 2 h, 8 and 14 days of macrophage infection.
Intracellular survival rates were calculated by relating the CFU
after 8 and 14 days to those at 2 h. By this, we observed similar
intracellular survival rates for MAPwt and MAPmptD rep-
resentatively shown for RAW264.7 macrophages in Figure 2A.
An interesting observation of these experiments was, however,
that the number of cultivable MAPmptD after 2 h of infec-
tion was significantly lower as compared to MAPwt (Figure 2B,
filled bars). This was true for MAP infection of RAW264.7 and
J774A.1 macrophages (Figure 2B). However, incubating MAPwt
and MAPmptD in macrophage whole cell lysates for 2 h led
to similar bacterial CFU counts indicating that exponentially
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FIGURE 2 | Survival and association of MAPwt and MAPmptD strain
in mouse macrophages. (A) Survival rates of MAPwt and MAPmptD in
RAW264.7 macrophages. Exponentially growing bacteria of MAPmptD
and MAPwt were harvested at OD600 of 1.0, and single cell suspensions of
an OD600 of 0.1 in DMEM were used to infect murine RAW264.7
macrophages as described in Materials and Methods. CFU were counted at
2 h, 8 and 14 days of macrophage infection. Intracellular survival rates were
calculated by relating the CFU after 8 and 14 days to those of 2 h. (B) CFU
numbers of bacteria after infection of mouse macrophages
(RAW264.7/J774.A1) with MAPwt and MAPmptD for 2 h (filled bars) and
after incubation of the strains in macrophage cell lysates for 2 h (dashed
bars). The results represent the mean ± standard error (s.e.m.) of at least
three independent replicates for the macrophage infections and two
replicates for the incubation in macrophage lysates. (C) Association and
invasion of CFSE labeled MAP wild type and MAPmptD strains in
J774.A1 macrophages after 2 h incubation with (+) and without (−)
latrunculin (Lat.). The statistical analysis was performed using a parametric
t-test (CFU) or a One-Way ANOVA combined with Dunnett’s multiple
comparison test (CFSE experiments). A p-value ≤ 0.05 was defined as
statistically significant (∗∗p < 0.005; ∗p < 0.05).
growing mutant and wild type strain had similar capability to
survive in this environment (Figure 2B, dashed bars).
Next we analyzed whether the lower levels of cultivable
MAPmptD after macrophage infection resulted from lower
adhesion of MAPmptD to macrophages and/or decreased up-
take of MAPmptD by the macrophages. For this, we per-
formed FACS analyses of untreated and latrunculin-treated
J774A.1 macrophages incubated with CFSE-labeled MAPwt and
MAPmptD. Non-infected macrophages were included as neg-
ative control. As shown in Figure 2C, no difference between
MAPwt and MAPmptD bacteria at the level of general asso-
ciation with macrophages (adherent and intracellular mycobac-
teria) was observed. Also the level of adhesion was similar
(Figure 2C, latrunculin treated macrophages). Together these
results suggested that the reduced cell number of MAPmptD
in macrophage compartments was due to a hampered adapta-
tion of MAPmptD to the early phagosomal environment of
macrophages.
MAPmptD IS ATTENUATED AFTER PERITONEAL CHALLENGE OF
MICE
The infection experiments of macrophage cultures revealed that
MAPmptD is hampered in intracellular survival and indicated
thatmptDmight be important for survival in the host. Therefore,
to analyze survival of MAPmptD and MAPwt in a more com-
plex system, we infected C57BL/6 mice intraperitoneally with
1 × 108 or 2 × 108 bacteria of exponentially growing cultures
of OD600 of 1.0 and animals were sacrified 4 weeks post infec-
tion. As shown in Figure 3, compared to the untreated controls,
mycobacteria infected mice exhibited increased liver and spleen
weight which was more pronounced in the animals infected
with the higher infection dose (Figures 3A,D). In lower dose
infections, a significant increase in spleen weight was observed
in wild type-infected mice but not in mice infected with the
mutant (Figure 3D). The CFUs in liver tissue were higher in wild
type-infected than in mutant-infected mice (Figure 3B). These
differences became significant when the higher infection dose
was used. Correspondingly, a higher number of granuloma was
counted in HE-stained histological sections (Figure 3C, Suppl.
Figure S1), however, no significant difference in granuloma sizes
was detected (data not shown). We have recently observed that
after i.p. infection of mice, MAP persists in large numbers in
mesenteric macrophages (Suwandi et al., in press). Therefore,
we also analyzed CFU in the mesentery. As shown in Figure 3E,
also in this tissue MAPmptD was isolated in significantly lower
numbers than MAPwt. Overall, our animal experiments indi-
cate a significantly lower biological fitness of MAPmptD in the
mouse infection model.
MAPmptD EXHIBITS AN ALTERED LIPID METABOLISM
In order to determine the functional cause for the decreased
survival of MAPmptD in macrophages and its attenua-
tion in a mouse infection model, comparative metabolomic
profiling was performed to detect differences in metabolite
concentrations between MAPmptD and its parental strain.
The concentrations of 175 metabolites in MAPwt and the
MAPmptD were compared (Suppl. Table S2). Among the 175
metabolites, the abundances of 32 were significantly different
(Figure 4A). Means and standard deviation for the three exper-
iments are shown in Table 1. Different relative abundances for
13 lipids and lipid-intermediates, 5 carbohydrates (mannose,
xylose, xylite, tagatose, threitol), 4 amino acids (lysine, arginine,
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FIGURE 3 | Biological fitness of MAP wild type (MAPwt) and mptD
mutant strain (MAPmptD) in infected mice. C57BL/6 8 week old
female mice were infected with either 1∗108 (open symbols) or 2∗108 cells
(black symbols) of MAPwt (circle) and MAPmptD (triangle) for 4 weeks.
DPBS buffer was used for the control group (ctrl, squares). The read out
parameters for this experiment were the weight of liver (A) and spleen
(D), CFU detection of bacteria from liver (B) and mesentery (E) as well as
the amount of granuloma in the liver (C). The results represent the mean
± standard error (s.e.m.) of animal experiments with 7–10 mice of each
group. The statistical analysis was performed using One-Way ANOVA
analysis (Kruskal–Wallis test). A p-value ≤ 0.05 was defined as statistically
significant (∗∗∗p < 0.0005; ∗∗p < 0.005; ∗p < 0.05).
pyroglutamine, tyrosine), 2 nucleobases (guanine, adenine), 4
nucleotides (adenosine, deoxycytidine, guanosine-5-phosphate,
methyladenosine), as well as the abundance of hippurate, citric
acid, FAD and the CoA precursor panthetheine were found in
MAPmptD. Twelve metabolites had a reduced abundance and
20 an increased abundance in MAPmptD (Table 1).
To examine the consequences of the marked differences in
lipid metabolites, crude lipids were extracted from MAPwt and
MAPmptD, fractionated on silica gel columns and analyzed
by thin-layer chromatography. In almost all fractions, we found
differential band pattern of lipids in MAPmptD compared to
its parental strain (Figures 4B,C). These analyses confirmed the
severe changes in lipid metabolism suggested by our metabolic
analyses. Overall, these data clearly show the presence of a deregu-
lated lipid metabolism with severe alteration of central metabolic
processes in MAPmptD.
DISCUSSION
The pathogenesis of JD is still only partially resolved. In con-
trast to other pathogenic mycobacteria, MAP is very slow grow-
ing and mycobactin-dependent in culture (Merkal and Curran,
1974). Furthermore, unlike the related M. avium ssp. hominis-
suis, MAP exhibits a strong tissue tropism to the gut which is not
seen in other mycobacteria. These phenotypical features might
be attributed to MAP-specific genotypical features. Thus, MAP
possesses eight common MAP-specific LSPs (Alexander et al.,
2009). Thirty-four MAP genes are not present in other mycobac-
teria species; 13 of these genes are most probably acquired from
other Actinomycetales and 21 genes without a homology to other
bacteria have been sequenced so far. Although MAP-specific ele-
ments are promising candidates for explaining the peculiarities of
MAP, the knowledge concerning their relevance in pathogenicity
is poor.
The mptD gene is one of the MAP-specific genes not present
in any other yet sequenced mycobacterial species. It is expressed
from the 38 kb pathogenicity island within the LSP14. LSP14
contains mainly genes assigning to metal acquisition (Stratmann
et al., 2004; Alexander et al., 2009). This predicted function
refers a particular importance to LSP14 as it might contain a
putative, alternative iron uptake locus, supplementing for MAP
mycobactin deficiency caused by a truncatedmbtA gene (Li et al.,
2005). In addition to its location on LSP14, the fact that mptD
was shown to be expressed during infection (Stratmann et al.,
2004) suggests a possible role of mptD in metabolism in the host
environment and in pathogenicity.
Our studies with the mptD mutant strain clearly denote
the important standing of mptD for MAP metabolism and
pathogenicity. We were not able to restore the MAPmptD phe-
notype by complementation of the MAPmptD with wild-type
mptD or the complete operon (data not shown), most likely
due to the complex organization of the predicted transporter
proteins and their yet unknown regulation. Yet we found no evi-
dence for alterations on the genome level except the deletion of
the gene itself which might be responsible for the MAPmptD
phenotype.
Overall, MAPmptDwas considerably hampered with respect
to survival in macrophages and in mice. Most probably
MAPmptD is not fully able to resist phagosomal factors to
which it is exposed during the first 2 h after infection. This
is strongly suggested since the logarithmically grown bacteria
showed similar survival after 2 h of incubation in the macrophage
cytosol but the survival ofMAPmptDwas strongly reduced after
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FIGURE 4 | GC/LC-MS analysis of metabolites (A) and HPTLC
analysis of lipids (B,C) from MAPwt and MAPmptD. (A) The heat
map illustrates the significant concentration changes (overall results of
three biological replicates). The color intensity and tones represent
magnitude and direction of metabolic changes, respectively, with the
magnitude of change ranging from white (reference) to red (positive
deviation to reference) or blue (negative deviation to reference). (B,C)
HPTLC analysis of polarity-fractionated lipids. Mobile phase in (B)
chloroform/methanol 18:2 (v/v); in (C) chloroform/methanol/water 65:25:4
(v/v/v). Lane 1: crude lipids from MAPmptD; lanes 2, 4, 6 and 8:
fractions of MAPwt; lanes 3, 5, 7, and 9: fractions of MAPmptD;
lanes 2 and 3: chloroform fraction; lanes 4 and 5: acetone fraction;
lanes 6 and 7: methanol fraction; lanes 8 and 9: chloroform/methanol
1:1 (v/v) column wash; lane 10: TDM standard; Lane 11: PIM standard
(see text) yellow arrows = additional bands; yellow boxes = same
bands with different intensities.
2 h macrophage infection. The observed long-term survival of
MAPmptD after infection of macrophages and in mice, how-
ever, indicates that the absence ofmptD does not lead to a general
attenuation thereby indicating an important role ofmptD in early
infection immediately after encountering the hostile environment
of the early phagocytic vacuole.
Our metabolic analyses clearly show that reduced survival is
correlated with an altered metabolism of MAPmptD. Metabolic
analyses revealed a reduced activity of the TCA cycle in
MAPmptD which was indicated by the negative deviation of
citric acid. This might be caused by a lower availability of acetyl-
CoA induced by an enhanced acetyl-CoA consuming fatty acid
synthesis, which is suggested by the accumulation of nine fatty
acidmetabolites. In addition, the activity of the TCA cycle appears
to be stressed by carbon efflux used for the generation of argi-
nine and lysine. Increased fatty acid synthesis is also reflected
by a higher activity of the pentose phosphate pathway which
is deducible from the accumulation of nucleosides and FAD.
The three fatty acid metabolites with negative deviation and the
accumulation of FAD indicate an enhanced β-oxidation of fatty
acids to generate acetyl-CoA in MAPmptD which, however,
seems not to satisfy the demand. This metabolic derailment in
MAPmptD might be enforced by a diminished CoA availabil-
ity as indicated by significantly diminished levels of panteth-
eine, an intermediate for CoA formation. Furthermore differ-
ential carbohydrate conversion in MAPmptD is indicated by
the accumulation of mannose and xylose, a precursor of ara-
binose (Wolucka, 2008). Mannose and arabinose are principal
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Table 1 | Relative abundance of significantly differential metabolites (MAPmptD vs. MAPwt).
Metabolite name Technique Fold change Metabolic classification
LMGL03011824* LC 11.8 Lipid transport and metabolism
Lysine GC 8.0 Amino acid metabolism
Glycerylphosphorylethanolamine LC 7.1 Lipid transport and metabolism
LMPR01070205* LC 6.5 Lipid transport and metabolism
LMGL02010112* LC 5.0 Lipid transport and metabolism
Deoxycytidine LC 4.2 Nucleic acid metabolism
LMST03020221* LC 3.6 Lipid transport and metabolism
LMFA06000087* LC 3.1 Lipid transport and metabolism
Adenosine LC 3.0 Nucleic acid metabolism
Arginine LC 2.8 Amino acid metabolism
GPEtn(18:0/0:0) LC 2.7 Lipid transport and metabolism
Pyroglutamic acid GC 2.3 Amino acid metabolism
Adenine LC 2.1 Nucleic acid metabolism
Guanosine-5-monophosphate GC 2.1 Nucleic acid metabolism
LMGL02070004* LC 2.0 Lipid transport and metabolism
GPEtn(16:0/0:0) LC 1.9 Lipid transport and metabolism
Guanine LC 1.8 Nucleic acid metabolism
Mannose GC 1.7 Carbohydrate metabolism
Xylose GC 1.7 Carbohydrate metabolism
Flavin adenine dinucleotide (FAD) LC 1.4 Co-factor metabolism
LMGL02070005* LC −1.4 Lipid transport and metabolism
Hippuric acid LC −1.5 Amino acid metabolism
Xylitol GC −1.6 Carbohydrate metabolism
LMGP02030001* LC −1.6 Lipid transport and metabolism
Tyrosine GC −2.0 Amino acid metabolism
LMGP03010004* LC −2.4 Lipid transport and metabolism
1-Methyladenosine LC −2.5 Nucleic acid metabolism
Citric acid GC −2.7 Carbohydrate metabolism
Threitol GC −3.1 Carbohydrate metabolism
Tagatose GC −3.6 Carbohydrate metabolism
Pantetheine LC −7.6 Co-factor metabolism
LMGL03011893* LC −7.7 Lipid transport and metabolism
*LIPID MAPS ID according to the LIPID MAPS Structure Database (http:// www .lipidmaps.org/ data/ structure/ index.html).
components of important cell envelope constituents such as
lipoamannan (LM), lipoarabinomannan (LAM), and arabino-
galactan (Brennan, 2003).
MAP possesses ∼300 genes involved in lipid metabolism and
the highest number of redundant genes for this metabolic extent
among pathogenic mycobacteria (Li et al., 2005; Marri et al.,
2006). The most obvious changes in MAPmptD were seen in
the lipid metabolism (Figures 4B,C). This is in accordance with
the reduced survival in macrophages and in mice since fatty acid
metabolism in pathogenic mycobacteria has been shown to be
essential for the survival of the bacterium in the host (Russell
et al., 2010). On the one hand, the solid cell wall with mycolic
acids and lipoglycans such as LAM and LM, produced from elon-
gated fatty acids, provides a protective lipid layer (Rowe and
Grant, 2006; Hett and Rubin, 2008), on the other hand lipids are
implicated as major nutrient sources of pathogenic mycobacteria
in the host. Thus, mRNA expression analysis of M. tuberculosis
(Mtb) obtained from macrophages in vitro and from the lungs
of mice and humans implied that Mtb changes its intermediary
metabolism in vivo by using host-derived lipids such as choles-
terol during the course of infection rather than using glucose
and glycerol, the primary carbon sources metabolized in vitro
(Schnappinger et al., 2003; Timm et al., 2003; Talaat et al., 2004).
More recently, it was shown that cholesterol degradation appears
to be important for feeding Mtb during chronic infection (Miner
et al., 2009). Accordingly, we have recently shown that, in the
host, MAP increases the activity of the TCA cycle by enhancing
β-oxidation of lipids, most probably cholesterol (Weigoldt et al.,
2013).
Our data indicate that a dysfunction of the balanced lipid
metabolism necessary for survival of MAP in the host might be
responsible for the attenuation of MAPmptD in macrophages
and in mice. The exceptional role of the mycobacterial lipid
metabolism for mycobacterial survival has been emphasized in
many studies (Russell et al., 2010). Disorders in the lipid home-
ostasis can dramatically influence mycobacterial viability. For
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example, exhaustive degradation of cholesterol or other lipids
may result in the accumulation of stable catabolic intermediates
such as propionate which, if not detoxified, may reduce biological
fitness (Chang et al., 2009). In addition, within the phagosome,
MAP has to resist other microbicidal defense mechanism, e.g.,
changing levels of bivalent cations such as Fe, Cu, Zn (Soldati and
Neyrolles, 2012). The predicted function of mptD as part of an
ABC transporter systems and its location on LSP14 suggestmptD
to be involved in ion homeostasis and imply that bivalent cations
may serve as important regulators for balancing lipid metabolism
of MAP during adaptation to the intracellular environment. Even
though the precise function of mptD is not yet known, our study
exemplified that MAP-specific elements have a considerable role
in MAPmetabolism and give novel insights into their importance
for metabolic adaptation of MAP to the host environment.
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